Header placeholder lorem ipsum dolor sit amet, consectetur adipiscing elit.
ResMed financials data including stock price, CreditSafe score, income statement, balance sheet, cash flow, and acquistions and subsidiaries.
Stock Price
$244.4
2024-10-29
Market Capitalization
$35.9 B
2024-10-29
Revenue
$4.7 B
FY, 2024
CreditSafe Score
?
Score changed on Dec 02, 2024
Premium Content only available in Craft’s Intelligence Portal
View 30+ financial ratio metrics including price-to-earnings ratio, debt-to-assets ratio, gross profit margin, and more.
Financial ratio metrics help evaluate the financial strength of a company, and help raise red flags that can indicate potential risk, fulfillment challenges, or even possible bankruptcy.
Learn moreFinancial Statements
| USD | FY, 2022 | FY, 2023 | FY, 2024 |
|---|---|---|---|
| Revenue | 3.6B | 4.2B | 4.7B |
| Cost of goods sold | 1.6B | 1.9B | 2.0B |
| Gross profit | 2.0B | 2.4B | 2.7B |
| Gross profit margin, % | 56.6% | 55.8% | 56.7% |
| General and administrative expense | 739.4M | 874.0M | 917.1M |
| Operating expense total | 1.0B | 1.2B | 1.3B |
| Depreciation and amortization | 31.1M | 42.0M | |
| EBIT | 1.0B | 1.1B | 1.3B |
| EBIT margin, % | 28.0% | 26.8% | 28.2% |
| Investment income | (20.7M) | 2.7M | (1.8M) |
| Interest expense | 22.3M | 47.4M | 45.7M |
| Pre tax profit | 960.5M | 1.1B | 1.3B |
| Income tax expense | 181.0M | 204.1M | 243.8M |
| Net Income | 779.4M | 897.6M | 1.0B |
| EPS | 5.3 | 6.1 | 6.9 |
Acquisitions & Subsidiaries
| Company name | Date | Deal size |
|---|---|---|
| Lorem | Dec 23, 2021 | $40.0M |
| Ipsum | Jan 18, 2022 | $30.0M |
| Lorem Ipsum | Feb 18, 2022 | $25.0M |
| Dolor | Oct 21, 2021 | $60.0M |
Premium Content only available in Craft’s Intelligence Portal View acquisitions and subsidiaries by company, date, and deal size. Understanding this data enables better supplier & customer negotiations and helps identify potential opportunities or market risks for your firm. Learn more |